The pathogenetic role of Th17-cells in MS could be explained by their ability to migrate into the CNS through the blood-brain barrier by the expression of chemokine receptor-6 [CCR6 (CD196)] and IL-17 production (10). This evidence concerns the gene IL17A and myeloid sarcoma.